| 30/09/26 | 13:00:00 | 30 Sept 2026 | | Interim Results for the Six Months to June 30, 2026, and Business Update | GNW |
| 25/09/26 | 07:00:00 | 25 Sept 2026 | | The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer | GNW |
| 16/09/26 | 16:00:00 | 16 Sept 2026 | | Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial | GNW |
| 14/09/26 | 07:00:00 | 14 Sept 2026 | | Avacta Appoints Mats Blom to the Board of Directors as Chair of Audit Committee | GNW |
| 08/07/26 | 07:00:00 | 8 Jul 2026 | | Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors | GNW |
| 01/06/26 | 07:00:00 | 1 Jun 2026 | | Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026 | GNW |
| 19/05/26 | 07:14:00 | 19 May 2026 | | Unaudited Preliminary Results for the Year Ended December 31, 2025 | GNW |
| 06/05/26 | 07:00:00 | 6 May 2026 | | Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 | GNW |
| 21/04/26 | 17:00:00 | 21 Apr 2026 | | Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform | GNW |
| 02/04/20 | 08:00:04 | 2 Apr 2020 | | Subscription to raise £2 million | RNS |
| 26/03/20 | 11:05:39 | 26 Mar 2020 | | Second Price Monitoring Extn | RNS |
| 26/03/20 | 11:00:24 | 26 Mar 2020 | | Price Monitoring Extension | RNS |
| 24/03/20 | 14:06:24 | 24 Mar 2020 | | Second Price Monitoring Extn | RNS |
| 24/03/20 | 14:00:32 | 24 Mar 2020 | | Price Monitoring Extension | RNS |
| 16/03/20 | 16:42:53 | 16 Mar 2020 | | Second Price Monitoring Extn | RNS |
| 16/03/20 | 16:38:14 | 16 Mar 2020 | | Price Monitoring Extension | RNS |
| 10/03/20 | 07:00:07 | 10 Mar 2020 | | Shareholder/Investor Meeting and Presentation | RNS |
| 13/02/20 | 07:00:07 | 13 Feb 2020 | | Notice of Results | RNS |
| 11/02/20 | 07:00:03 | 11 Feb 2020 | | Share Incentive Plan/Issue of Equity | RNS |
| 03/02/20 | 07:00:08 | 3 Feb 2020 | | Avacta and Daewoong Agreement | RNS |
| 29/01/20 | 14:45:08 | 29 Jan 2020 | | Holding(s) in Company | RNS |
| 28/01/20 | 07:00:13 | 28 Jan 2020 | | Successful initial proof-of-concept | RNS |
| 23/01/20 | 07:00:04 | 23 Jan 2020 | | Trading Update | RNS |
| 21/01/20 | 07:00:14 | 21 Jan 2020 | | Director Appointment | RNS |
| 08/01/20 | 07:00:05 | 8 Jan 2020 | | Avacta and Daewoong Establish Joint Venture | RNS |
| 26/11/19 | 09:00:44 | 26 Nov 2019 | | Holding(s) in Company | RNS |
| 22/11/19 | 08:41:49 | 22 Nov 2019 | | Director/PDMR Shareholding | RNS |
| 13/11/19 | 07:00:03 | 13 Nov 2019 | | LG Chem Life Sciences Expands Partnership | RNS |
| 08/11/19 | 18:30:03 | 8 Nov 2019 | | Holding(s) in Company | RNS |
| 08/11/19 | 18:26:01 | 8 Nov 2019 | | Holding(s) in Company | RNS |
| 07/11/19 | 13:00:02 | 7 Nov 2019 | | Holding(s) in Company | RNS |
| 07/11/19 | 11:00:01 | 7 Nov 2019 | | Holding(s) in Company | RNS |
| 06/11/19 | 14:30:02 | 6 Nov 2019 | | Holding(s) in Company | RNS |
| 04/11/19 | 13:18:33 | 4 Nov 2019 | | Result of General Meeting | RNS |
| 18/10/19 | 13:06:57 | 18 Oct 2019 | | Proposed Placing & Subscription to raise up to £9M | RNS |
| 10/10/19 | 08:00:04 | 10 Oct 2019 | | Collaboration with ADC Therapeutics | RNS |
| 05/08/19 | 10:05:45 | 5 Aug 2019 | | Second Price Monitoring Extn | RNS |
| 05/08/19 | 10:00:33 | 5 Aug 2019 | | Price Monitoring Extension | RNS |
| 29/07/19 | 08:00:10 | 29 Jul 2019 | | Avacta's CEO to Present at Biotech Investor Day | RNS |
| 20/06/19 | 08:00:03 | 20 Jun 2019 | | Avacta and Selexis Partner to Develop Cell Line | RNS |
| 19/06/19 | 08:00:05 | 19 Jun 2019 | | Turner Pope Investor Evening | RNS |
| 12/06/19 | 08:00:06 | 12 Jun 2019 | | Avacta's CSO to Present at Major US Conference | RNS |
| 10/06/19 | 08:00:04 | 10 Jun 2019 | | Avacta hits Clinical Candidate Selection Milestone | RNS |
| 03/06/19 | 08:00:05 | 3 Jun 2019 | | TMAC Programme Accelerates | RNS |
| 23/04/19 | 16:48:37 | 23 Apr 2019 | | Issue of Equity | RNS |
| 12/04/19 | 15:46:50 | 12 Apr 2019 | | Holding(s) in Company | RNS |
| 09/04/19 | 08:00:05 | 9 Apr 2019 | | Interim Results | RNS |
| 08/03/19 | 12:14:19 | 8 Mar 2019 | | Issue of Equity | RNS |
| 04/02/19 | 07:00:04 | 4 Feb 2019 | | Moderna Exercises Exclusive Product License Option | RNS |
| 28/01/19 | 07:00:06 | 28 Jan 2019 | | Director Appointment | RNS |
